The board of directors of California’s BioMed Realty Trust, a major owner of biotechnology and medical space in the Boston area, has declared a second quarter dividend of 15 cents per share of common stock.

The payment represents a 7.1 percent increase over the company’s first quarter dividend of 14 cents per share, and is equivalent to an annualized dividend of 60 cents per common share, the company said.

BioMed’s board also declared a dividend of $0.46094 per share of the company’s 7.375 percent Series A Cumulative Redeemable Preferred Stock for the period of April 16 through July 15.

Both dividends are payable July 15 to stockholders of record at the close of business on June 30.